Zoetis Inc. Professional Fees
Zoetis Inc. (ZTS) reported Professional Fees of $14.00 million for the 9-month period ending 2016-10-02, per its 10-Q filed 2016-11-03.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProfessionalFees · last filed 2017-05-04
- Zoetis Inc. professional fees for the quarter ending 2016-10-02 was $4.00M.
- Zoetis Inc. professional fees for the quarter ending 2016-07-03 was $5.00M.
- Zoetis Inc. professional fees for the quarter ending 2016-04-03 was $5.00M.
| Period end | Professional Fees 3 month | Professional Fees 6 month | Professional Fees 9 month |
|---|---|---|---|
| 2016-10-02 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $9.00M derived: sum of 2 quarters · filed 2016-11-03 | $14.00M 10-Q · filed 2016-11-03 |
| 2016-07-03 | $5.00M 10-Q · filed 2016-08-05 | $10.00M 10-Q · filed 2016-08-05 | |
| 2016-04-03 | $5.00M 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |